Conflicts of interest common among US cancer guideline authors, study findsBMJ 2016; 354 doi: https://doi.org/10.1136/bmj.i4660 (Published 25 August 2016) Cite this as: BMJ 2016;354:i4660
- Michael McCarthy
More than 85% of the authors of national cancer guidelines had at least one financial conflict of interest in 2014, a US study has found.1 The researchers found that the authors received an average of more than $10 000 (£7600, €8900) from the drug and device industry in general payments relating to such things as consulting, meals, and lodging and $236 000 in payments relating to research, including funding associated with clinical trials.
In the study, researchers from Chapel Hill School of Medicine at the University of North Carolina determined the financial conflicts of interest of 125 authors contributing to the …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial